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Objective: To determine DNA ploidy in the cervical specimens of patients revealing a suspicion of cancer
by image analysis performed by using a combination of commercial analysis software, conventional
microscopy, and certiﬁed ﬁlters.
Materials and methods: This study followed a prospective design. Cervical samples were obtained from
20 patients undergoing routine screening in the Gynecologic-Oncology Unit of the University Hospital of
the Federal University of Minas Gerais, Brazil. Three slides were prepared for each case and the DNA
content was determined by image cytometry, post Feulgen staining. DNA ploidy, as well as events
exceeding 5C and 9C, was assessed according to the guidelines and algorithms prescribed for diagnostic
interpretation by the European Society for Analytical Cellular Pathology.
Results: By employing the adapted tool, identiﬁcation of the lesions with euploid and aneuploid proﬁles
was possible. Abnormal DNA content was found in 65% of the cases (13/20), with 45% (9/20) presenting
nuclei with >5C content and 20% (4/20) with >9C content. In the analyses conducted in this study, the
coefﬁcient of variation with respect to DNA quantity was lower than the 5% threshold recommended by
the European Society for Analytical Cellular Pathology.
Conclusion: Image cytometry of the cervical specimens revealed DNA aneuploidy, most probably
resulting from chromosomal alterations and appearing as precancerous lesions in 65% of the cases. The
adaptations implemented in this study, enabled the DNA-image cytometry to become more accessible,
enhancing its extended use as an adjuvant strategy for the early screening of the cervical epithelium
samples during routine analyses.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Cervical cancer has become one of the most common tumors
detected in women worldwide, accruing approximately 530,000
cases and 275,000 deaths annually [1]. Tumors arise from pre-
invasive precursor lesions with a slow progression rate, which
enables detection and identiﬁcation right at the initial phase [2].
The Papanicolaou smear is the universally used diagnostic method
to detect cervical cancer [3]. Although this procedure has signiﬁ-
cantly reduced by as much as 75% of the number of deaths bye Citometria, Departamento
EP: 36570-000 Viçosa, MG,
bstetrics & Gynecology. Publishedcervical cancer [4], considerable variation in its sensitivity and
speciﬁcity has been reported [5e7]. Furthermore, this method is
limited by the interpretation of the morphology, with little or no
information regarding the risk of persistence, progression or
regression and reveals large interobserver variability [8]. According
to B€ocking, neither histologic nor cytologic evaluation can predict
whether the dysplastic cells will progress to carcinoma in an in-
dividual patient. Therefore, the early identiﬁcation of precancerous
changes remains a challenge [9].
Adjuvant diagnostic methods such as colposcopy, detection, and
molecular typing of HPV and DNA image cytometry (ICM) have also
been proposed. DNA-ICM is being used as a complementary de-
tective method in clinical analyses in more than 40 laboratories
across the United States, Europe, and Asia [10].
Combining microscopy and digital image analysis the DNA-ICM
technique evaluates the stoichiometric nuclear DNA staining postby Elsevier Taiwan LLC. All rights reserved.
Table 1
Summary of results from 20 cases analyzed by DNA-image cytometry showing total
number of nuclei and nuclear DNA ploidy.
Case Total
nuclei
Nuclear DNA ploidy from three repetitions
01 327 Main peak at 2C and aneuploid nuclei 5cEEa ¼ 63; 9cEEb ¼ 5
02 363 Main peak at 2C and aneuploid nuclei 5cEE ¼ 3; 9cEE ¼ 0
03 293 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
04 315 Main peak at 2C and aneuploid nuclei 5cEE ¼ 3; 9cEE ¼ 0
05 179 Main peak at 2C and aneuploid nuclei 5cEE ¼ 1; 9cEE ¼ 0
06 385 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
07 303 Main peak at 2C and aneuploid nuclei 5cEE ¼ 5; 9cEE ¼ 0
08 625 Main peak at 2C and aneuploid nuclei 5cEE ¼ 29; 9cEE ¼ 4
09 232 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
10 299 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
11 149 Main peak at 2C and aneuploid nuclei 5cEE ¼ 8; 9cEE ¼ 0
12 644 Main peak at 2C and aneuploid nuclei 5cEE ¼ 21; 9cEE ¼ 1
13 183 Main peak at 2C and aneuploid nuclei 5cEE ¼ 2; 9cEE ¼ 0
14 408 Main peak at 2C and aneuploid nuclei 5cEE ¼ 30; 9cEE ¼ 4
15 341 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
16 318 Main peak at 2C and aneuploid nuclei 5cEE ¼ 25; 9cEE ¼ 0
17 255 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
18 311 Main peak at 2C and aneuploid nuclei 5cEE ¼ 22; 9cEE ¼ 0
19 259 Main peak at 2C and 5cEE ¼ 0; 9cEE ¼ 0
20 375 Main peak at 2C and aneuploid nuclei 5cEE ¼ 5; 9cEE ¼ 0
a5cEE: 5C-exceeding events; b9cEE: 9C-exceeding events. Acronyms represent
nonproliferating abnormal cells with different chromosomal aneuploidies and
abnormally high number of chromosomes [12].
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the DNA stem lines outside the euploid regions as abnormal (or
aneuploid) at a deﬁned statistical level of signiﬁcance [12].
This method enables the quantiﬁcation of DNA ploidy by
generating a quantitative cytometric equivalent of chromosomal
ploidy, which can be conducted even in resting cells [12]. DNA
aneuploidy is a proven good marker for prospective malignancy, as
the chromosomal changes are related to malignant and premalig-
nant lesions [13e15]. Thus, DNA image cytometry should provide
information regarding the presence of rare cells with an abnor-
mally high DNA content [12], attempting to distinguish the pro-
spective malignant lesions from microscopically atypical or
otherwise suspect cells. In various tissues, DNA-ICM has predicted
malignant transformation, with high sensitivity and speciﬁcity
[14,16,17]. Further, this technique has been recognized as a quan-
titative and reproducible method for the diagnosis of intraepithelial
cervical lesions [18].
Image analysis using microscopic systems requires suitable and
speciﬁc software tools for cell analysis, despite the high cost and
limited availability [19]. In this work, a particular image analysis
method was performed, using a combination of commercial anal-
ysis software (Image Pro-Plus 6.1 Media Cybernetics, Rockville, MD,
USA), conventional microscopy, and certiﬁed ﬁlters. Furthermore,
changes in the internal standard type and in the slide preparation
method were adopted to yield more accurate DNA ploidy
measurements.Materials and methods
Conducted on the lines of prospective design, this study
involved the collection of cervical epithelium samples from 20
women undergoing routine screening at the Gynecologic-oncology
ward of the University Hospital of the Federal University of Minas
Gerais, Brazil, between December 2006 and February 2007. Patients
were categorized by conventional cytology as having a low-grade
lesion, high-grade lesion, or being negative for an intraepithelial
lesion or malignancy (NILM). For analysis, the physician selected
only samples suspicious for cancer, whereas DNA-ICM was per-
formed independently, without knowledge of the clinical evalua-
tion. Epithelium from the oral mucosa of clinically healthy women
was used as control. The participants were informed regarding the
purpose of the research and signed consent was taken from them.
This study was approved by the Local Ethics Committee of the
Federal University of Minas Gerais (coep ETIC 326/08).Sample preparation and staining
The samples were collected in a universal cytological liquid
(LucBASE, Florianopolis, Brazil) and ﬁxed in 70% ethanol at 20C
(Merck KGaA, Darmstadt, Germany). Three slides were prepared for
each patient by cytocentrifugation (Presvac, Balneario Camboriú,
Brazil). A modiﬁed internal standard material was introduced,
consisting of a cell suspension of the oral mucosa (reference cells).
The reference cells and a sample of the cervical epithelium, were
mounted on opposite ends of each slide [20]. Feulgen reaction was
performed according to Gonçalves et al [18] and Carvalho et al [20].
The slides were postﬁxed in 4% paraformaldehyde (Merck) for
60 minutes and then washed in running water. Subsequently, the
slides were hydrolyzed in 5M HCl (Merck) for 60 minutes at 24C
and stained with Schiff's reagent (Merck) for 12 hours at 4C, in the
dark. After washing the slides three times (for 2 minutes each time)
in 0.5% SO2 water, and again three times (for 1 minute each time) in
distilled water, they were air-dried. The slides were then mounted
in immersion oil and stored in the dark until image analysis.Image analysis system
The image analysis system for DNA measurements included a
photomicroscope (BX-60; Olympus, Center Valley, PA, USA)
equipped with a stabilized light source; UPlanFI objective 60/0.75;
interference ﬁlter (green color 550e570 nm); and a mono-
chromatic charge-coupled device digital video camera of 12-bit
gray (Photometrics CoolSNAP Pro; Roper Scientiﬁc, Tucson, AZ,
USA). The microscope was adjusted using the K€ohler method, prior
to the capture session of each slide.
The system was calibrated based on the recommendations of
Hardie et al [11], Puech and Giroud [21], Vilhar and Dermastia [22],
Mendonça et al [23], and basically involved three tests performed in
our laboratory: (1) stabilitydthe system acquired stability after
12 minutes, from the time it was connected [23]; (2) linearityd-
linear correlation between the optical density (OD) calculated by
the software and certiﬁed OD values was R2 ¼ 0.9978 [23]; and (3)
uniformitydthe OD determination of a nucleus was found to be
independent of its position in the visual ﬁeld [23].
UPlanFI objective magniﬁcation 60 and tools from the Image
ProPlus 6.1 analysis system (Media Cybernetics, Rockville, MD, USA)
were used to capture the nuclei images. The macro function pro-
gramming was used to automate the capture of the individual
nuclei. Approximately, 200e350 nuclei of the cervical epithelium
and at least 30 cell nuclei of the reference material were scanned
and segregated into groups for comparative analysis. Nuclei sam-
pling was performed in a semi-interactive manner, discarding
overlapping or poorly preserved nuclei and leukocytes.
Using the image analysis program Image Pro-Plus 6.1 the inte-
grated OD (IOD) was automatically calculated by multiplying the
nuclear area (mm2) by the OD of the object. IOD values were
rescaled in terms of the relative DNA content, based on the refer-
ence cells with a known DNA content [24]. SPSS 13.0 software
(Macintosh package version; SPSS, Chicago, IL, USA) was used to
calculate the modal IOD values in each repetition. The data gener-
ated were then plotted as nuclear DNA ploidy histograms for sta-
tistical assessment of the G0/G1 and G2/M peaks, according to
prescribed criteria of the European Society for Analytical Cellular
Pathology (ESACP) [24].
Fig. 1. Representative histograms and nuclei collections analyzed by image cytometry. (A) Histogram of oral epithelium nuclei used as control (internal standard). Main peak at 2C;
5C-exceeding events (5cEE) ¼ 0; 9C-exceeding events (9cEE) ¼ 0. (B) Corresponding nuclei collections. (C) Histogram from a Papanicolaou (Pap) smear diagnosed as negative for
intraepithelial lesion or malignancy showing normal DNA ploidy (Case 17). Main peak at 2C; 5cEE ¼ 0; 9cEE ¼ 0. (E) Histogram from a Pap smear diagnosed as high-grade lesion,
with DNA ploidy showing 5C-exceeding events (Case 16). Main peak at 2C; 5cEE ¼ 13; 9cEE ¼ 0. (G) Histogram from a Pap smear diagnosed as high-grade lesion, with DNA ploidy
showing 9C-exceeding events (Case 14). Main peak at 2C; 5cEE ¼ 5; 9cEE ¼ 2. (D, F, H) Cervical epithelium nuclei collection used for integrated optical density measurements and
elaboration of the respective histograms. Bar ¼ 10 mm.
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Based on the algorithms from the ESACP guidelines, a sample
was classiﬁed as diploid when only one peak was found in G0/G1
phase (2C), with <1% of the cells exceeding 5C and less than 10% in
the G2/M phase (4C). Aneuploidy was identiﬁed when the number
of nuclei exceeding 5C (5cEE) or 9C (9cEE) was >1% of the total
number of the nuclei analyzed [24]. DNA-ICM was conducted
without identifying the nature of the lesion.
Results
According to the classiﬁcation criteria, 35% of the cases sampled
(7/20) were considered normal, presenting only histograms with
the G0/G1 peak of diploid nuclei. Abnormal DNA content was
observed in 65% of the cases (13/20), with 45% (9/20) presenting
nuclei with content greater than 5C, and 20% (4/20) revealing
content more than 9C. The total number of nuclei analyzed and the
ratio of the aneuploid nuclei detected in each case are summarized
in Table 1.
In Fig. 1, four of the 120 nuclei collections used for the IOD
measurements and elaboration of the respective histograms are
represented. The histogram of the material used as control showed
the main peak at 2C, (diploid nuclei in G0/G1 phase; Fig. 1A). Fig. 1C
shows a normal DNA ploidy case histogram (main peak at 2C;
5cEE ¼ 0; 9cEE ¼ 0), while Fig. 1E and 1G represent histograms of
cases showing aneuploid nuclei (main peak at 2C; 5cEE > 0;
9cEE > 0). In such examples, the occurrence of nuclei with altered
morphology could be observed (Fig. 1FeH).
In all the samples analyzed, the coefﬁcient of variation (CV)
corresponding to the ratios between the modal IOD values of the
reference cells and nonpathologic G0/G1 cells ranged from 0.8% to
4.49%.
The DNA-ICM measurements in the different cytological sub-
groups are listed in Table 2. The high-grade lesion group revealed
increased DNA aneuploidy, while 40% (2/5) of the NILM smears
showed DNA aneuploidy.
Discussion
In this study, the steps in the image analysis system calibration
and the algorithms accomplished to identify precancerous and
cancerous lesions enabled the execution of quantitative analysis.
System calibration included stability, linearity, and uniformity tests,
and stability was achieved after 12minutes. According to Vilhar and
Dermastia [22], the stabilized light source prevents variations in
the OD values measured. In the linearity test, the calculated coef-
ﬁcient of determination (R2 ¼ 0.9978) fulﬁlls the requirements
(R2 > 0.9) for performing densitometric measurements [22]. The CV
obtained in the uniformity test was <1%. Values below 3% are
acceptable according to the international standards prescribed inTable 2
DNA-image cytometry measurements in the cytologic subgroups.
DNA-image cytometry (%)**
No. of cases Cytological diagnosis* 5cEE 9cEE Diploid
14 HSIL 7(50) 3(21) 4(29)
1 LSIL 1(100)
5 NILM 1(20) 1(20) 3(60)
*According to the Bethesda nomenclature system [2]; **According to the European
Society of Analytical Cellular Pathology [24].
5cEE ¼ 5C-exceeding events; 9cEE ¼ 9C-exceeding events; HSIL ¼ high-grade
lesion; LSIL ¼ low-grade lesion; NILM ¼ negative for intraepithelial lesion or
malignancy.the medical arena for DNA-ICM analysis [11]. Quality control of the
instrumentation used for analysis is the ﬁrst step required to
standardize the quantiﬁcation of nuclear DNA ploidy [21]. Our
laboratory fulﬁlled the requirements for application of the
technique.
Use of the cytocentrifuge for slide preparation is another
modiﬁcation introduced in this study. This procedure was used to
supply the ﬂattened cells uniformly scattered in a delimited circular
area, with slight overlapping and cell density per ﬁeld suitable for
DNA-ICM analysis.
Oral epithelial cells were used as the internal standard [18] as
their nuclear morphology has characteristics similar to the cervical
epithelial cells [25]. This raises the reliability of the rescaling step.
Two types of reference systems, namely external and internal, are
present, based on the ESACP guidelines. B€ocking and Nguyen [12]
recommend the use of the internal reference cells, which are pre-
pared in parallel with the clinical sample, because they have the
advantage of being subject to all the preparatory steps as the
clinical specimen cells being analyzed. Different cell types have
been used for the quantiﬁcation of nuclear DNA ploidy in tumors,
such as lymphocytes [14,16] and normal cells of the tissue being
analyzed [12,17,26]. However, the cytomorphologic differences
between the standard and analyzed samples, particularly with
respect to the nuclear area and the degree of chromatin conden-
sation are relevant factors for selection of the reference standard
[27]. These authors found that the degree of tumor ploidy could be
modiﬁed by the type of tissue used as the diploid reference stan-
dard. Furthermore, Grote et al [26] reported that the virus incu-
bation period should be considered when using normal cervix cells
as the reference, as they can generate histograms having a peri-
diploid DNA proﬁle.
In this study, the diploid populations and nuclei having DNA
content >5C and 9C were identiﬁed. Among the cases evaluated,
35% (7/20) were classiﬁed as diploid. According to B€ocking et al
[28], patients with a normal DNA histogram (main peak at 2C;
5cEE ¼ 0; 9cEE ¼ 0) may return to routine screening intervals.
Nuclei with DNA content >5C (main peak at 2C; 5cEE > 0; 9cEE¼ 0)
were identiﬁed in 45% of the samples (9/20), even among those
with a histopathologic diagnosis of NILM (2/5). Sun et al [29] sug-
gested that these patients be referred for additional tests, such as
colposcopy and biopsy. Nuclei with a DNA content >9C (main peak
at 2C; 5cEE > 0; 9cEE > 0) were detected in 20% (4/20) of the cases
evaluated and were classiﬁed as aneuploid lesions with poor
prognosis. Various authors report that the presence of DNA aneu-
ploidy deﬁnes a lesion of undetermined signiﬁcance as high-grade,
obligatory precancerous, or prospectively malignant [12,30].
B€ocking and Nguyen [12] recommend surgical intervention when
such aneuploid lesions with poor prognosis are identiﬁed.
On nuclei IOD analysis, the maximum CV measured was 4.49%.
This result is consistent with the medical DNA-ICM parameters,
which accept CV values below 5% [24]. The coefﬁcient value ob-
tained conﬁrms the adequacy of the procedures adopted.
Diagnostic DNA-ICM is an accurate and quantitative method
that has been internationally standardized. The DNA-ICM may
contribute to cut down the costs that result from repeated and
unnecessary cytologic, histologic and clinical controls [12]. In fact,
the expenses for such analyses are paid, for instance, by the German
health insurance in the cases of cytologically doubtful diagnoses
[31], and cost approximately 50 euros per measurement [12].
Furthermore, surgical intervention in DNA-ICM detected aneuploid
lesions also avoids the high costs that are normally incurred when
advanced carcinomas require treatment. This study adapted a
procedure for quantitative analysis of DNA ploidy by combining
commercial analysis software, conventional microscopy and certi-
ﬁed ﬁlters. Such an adaptation makes DNA-ICM more accessible,
C.E. Motta Duarte et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 227e231 231enabling the extended use of this tool as an adjuvant strategy for
early screening of the cervical epithelium samples during routine
analyses. Our results conﬁrm the immense beneﬁts of the DNA-ICM
methodology and validate its application as an effective auxiliary
diagnostic tool.
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